<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

4 min read

ASPN 2024: Research and Innovation in Interventional Pain

9/18/24 9:30 AM

ASPN v2 2024 copySmartTRAK reports the latest research and innovation in interventional pain management from ASPN 2024. 

Interventional pain management is rapidly evolving. Practitioners are expanding the tools in their toolbox beyond traditional pain therapies to offer patients a wider range of new and innovative treatment options in spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), minimally invasive spine and radiofrequency ablation as well as regenerative and restorative therapies.  

In this article, SmartTRAK highlights the latest research and innovation in interventional pain management from the American Society of Pain & Neuroscience (ASPN) Annual Conference, held July 11-14 in Miami, FL. The ASPN meeting has grown exponentially over the last several years and is a reflection of the growing interest in providing more treatment options to patients with chronic intractable pain. (See also SmartTRAK’s interview with ASPN Chairman Tim Deer, MD, ASPN 2024: Evolving Ideas into Innovation and Practice.)
 
Among the many topics covered in detail in this informative article are:
 

Spinal Cord Stimulation

  • Correlating Neurophysiological Data to Pain and Treatment Success
  • FAST US Real-World Data
  • Remote SCS Management
  • Data Supporting Expanded Indications
    • Nonsurgical Back Pain
    • Painful Diabetic Neuropathy
    • Nociceptive Pain

Peripheral Nerve Stimulation

  • Craniofacial, Head/Neck Pain
  • Comfort PNS Devices
  • Next Generation PNS Devices

Minimally Invasive Spine

  • Basivertebral Nerve Ablation (BVNA)
  • Minimally Invasive SI Joint Fusion
  • Lumbar Decompression for Lumbar Spinal Stenosis

Regenerative and Restorative Medicine

  • Intradiscal Therapy

Click the button below to download and read the complete "ASPN 2024: Research and Innovation in Interventional Pain" Market Outlook article by Anne Staylor, SmartTRAK Executive Editor, VP & GM of Neuro Therapies.

 


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

 

 

Anne Staylor
Written by Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles